Australia's most trusted
source of pharma news
Friday, 29 May 2026
Friday, 29 May 2026
Subscribe
Login
Serious adverse event warning
The TGA has issued a warning of the risk of serious adverse events after a number of bungled administration errors by doctors overseas, causing severe pain, seizures, cardiac arrhythmias and patient deaths.
Market leader falls for first time
ICYMI: There's been a major shift in industry's therapeutic focus with oncology toppled plus the other most popular stories this week
TODAY Your Week in 5 minutes
Industry pay stalls, feet get itchy
Average pay across Aussie pharma and life sciences stalls but that's not the only reason employees are eyeing other opportunities
TODAY
Senior exec leaves pharma
New job, new industry plus the other employment moves across industry, including a farewell after 26 years
28 May
Why Drs are losing trust in pharma
Uncoordinated messaging can leave HCPs with a low opinion of pharmas even when individual teams are successful
28 May
TGA teases four drug approvals
Four companies could be on the cusp of having their drugs approved by the TGA and at least one is a potential blockbuster
27 May
Drug pulled after viability review
Pharma to discontinue supply after assessing the commercial viability of its products and a review of future market demand and product volumes
27 May
Latest Jobs
Key Account ManagerClinical Trial InvestigatorSenior Group Financial AccountantTalent Acquisition CoordinatorSenior Medical ManagerStrategic Sales Director ANZ, Digital HealthStrategic Sales Director ANZ, Digital HealthSales Manager / Territory Manager24 more...
Pharma in Focus Jobs
Sales & Customer Relations (18)
- Key Account Manager - Melbourne
- Senior Group Financial Accountant - Victoria
- Strategic Sales Director ANZ, Digital Health - Melbourne
- Strategic Sales Director ANZ, Digital Health - Sydney
- Sales Manager / Territory Manager - Christchurch
- Business Development Manager – Health Tech - Melbourne
- Business Development Manager – Health Tech - Brisbane
- GP Representative - Geelong
- Business Development Manager, Health Tech - Sydney
- Territory Manager - Gold Coast
- Sales Director - Sydney
- Medical Sales Representative - Sydney
- Business Development Manager - Sydney
- Specialty Pharmaceutical Sales Representative - Queensland
- Surgical Sales Specialist - Auckland
- Surgical Sales Specialist - Auckland
- Customer Service Team Leader - Frenchs Forest
- Territory Manager - Melbourne
Clinical & Medical, R&D (5)
- Clinical Trial Investigator - Melbourne
- Senior Medical Manager - Melbourne
- Clinical Trial Start Up Specialist - Melbourne
- Medical Sales Representative - Sydney
- Clinical Trial Nurse Unit Manager - Melbourne
Regulatory, Pharmacovigilance & QA (3)
- Country Head, Regulatory Affairs, ANZ - Melbourne
- Regional Quality Head - Sydney
- Regulatory Submissions Specialist - Melbourne
Executive Roles (4)
- Strategic Sales Director ANZ, Digital Health - Melbourne
- Strategic Sales Director ANZ, Digital Health - Sydney
- Director of Operations, HealthTech - Melbourne
- Sales Director - Sydney
Other (7)
Backlash over Govt ad campaign
High-profile women's health campaign triggers anger from patients over two important drugs that are out of reach
TODAY
Investor targets 'untapped market'
Sydney-based private investment firm is spearheading a push to build business around women's health, committing $25M-plus
TODAY
Drug class doubles in one month
A third new approval has seen this drug class double in size in just one month, and marks the first-ever Australian product approval for the pharma
28 May
$17.7B bid to take pharma private
A private equity firm and Belgian investment group have launched a $17.7 billion bid to take this pharmaceutical company private
28 May
Lilly muscles into vaccine market
Obesity giant puts $5 billion-plud on the table for next-gen technologies that target diseases with no approved rivals
28 May
Exec exits with pointed sign-off
After 19 years with the same company this Sydney-based leader has left his role with the final word about 'organisational decisions'
27 May
Partnership boosts clinical trials
ARCS is levelling the playing field, launching a partnership to elevate professional development for public clinical research sites
27 May
Sanofi ends 100-year drought
TGA approval marks the biggest development in the field in more than a century, with the company actively pursuing reimbursement
27 May
Oncology dethroned as No 1
Oncology is no longer the largest contributor to late-stage pipeline value, increasing exposure to therapeutic area-specific shocks
26 May
Gladys takes health sector role
Former NSW Premier said leading the State through the pandemic had taught her the importance of preparedness and treatment
26 May
Seqirus scores vax funding win
Among other changes, a NZ proposal expands flu vaccine coverage to include kids for the first time, tapping CSL for the treatment
26 May
Ex-Aussie Country Boss collects prize
This pharma has been crowned Green Business of the Year, highlighting the company's efforts to align commercial goals with environmental targets
26 May
Who's facing $13.3M in legal costs?
A deal that went sour is far from over with one pharma ordered to pay its rival's hefty legal bill which it described as 'Rolls Royce'
26 May
Country Leader back after Gap Year
After more than 23 years at J&J followed by a year off for travel, time with family and getting fit, this boss is back in a new top role
25 May